ASHP Advantage: Immune Checkpoint Inhibitors in Cancer Treatment: Overcoming Challenges in Identifying and Managing Immune-related Adverse Events

In this podcast, expert faculty discuss the importance of timely identification and management of immune-related adverse events (irAEs) in patients being treated with immune checkpoint inhibitors, including commonly asked questions. 

 

To learn more about this initiative visit www.ashpadvantage.com/irae  

 

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.